2018 US Infectious Disease Testing Analyzers and Reagents: Supplier Sales and Shares by Test, Sales Segment Forecasts--Hospitals, Commercial Laboratories, POC Locations--Competitive Landscape, Emerging Technologies, Instrumentation Review

Publisher Name :
Date: 09-Jul-2018
No. of pages: 1060

Complete report $11,500. DataPack (test volumes, sales forecasts, supplier shares) $7,500.

VPGMarketResearch.com's new report is a strategic analysis of major business opportunities emerging in the infectious disease testing market during the next five years. The report examines key US market trends; reviews current and emerging assays; analyzes potential applications of innovative diagnostic technologies; forecasts volume and sales for over 100 infectious disease tests performed in hospitals, blood banks, commercial laboratories, physician offices, public health, ER, OR, ICU, cancer clinics, ambulatory care centers, surgery centers, nursing homes, and birth centers; provides test volume estimates by method (molecular, serology/immunodiagnostics, culture/microscopy); profiles leading players and potential market entrants; and suggests alternative business expansion strategies for suppliers.

Rationale

This comprehensive report will assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding microbiology testing market, in evaluating emerging opportunities and developing effective business strategies.

Microbiology testing is one of the most rapidly growing segments of the in vitro diagnostics industry, and the greatest challenge facing suppliers during this decade. Among the main driving forces is continuing spread of AIDS, which remains the world’s major health threat and a key factor contributing to the rise of opportunistic infections; threat of bioterrorism; advances in molecular diagnostic technologies; and a wider availability of immunosuppressive drugs.

Although for some infections the etiology is still a mystery, while for others the causative microorganisms are present in minute concentrations long before the occurrence of first clinical symptoms, recent advances in genetic engineering and detection technologies are creating exciting opportunities for highly sensitive, specific and cost-effective products.

Opportunities and Strategic Recommendations

- Emerging opportunities for new instrumentation, reagents kits, IT and other products with significant market appeal during the next five years.

- Design criteria for decentralized testing products.

- Alternative market penetration strategies.

- Potential market entry barriers and risks.

Infectious Diseases Analyzed in the Report

AIDS/HIV, Adenovirus, Aeromonads, Bartonella, Blastocystis Hominis, Campylobacter, Candida, Chancroid, Chlamydia, Clostridium, Coronavirus, Coxsackievirus, Cryptosporidium, Cyclospora, CMV, E. Coli, Echovirus, Encephalitis, Enterovirus, EBV, Giardia, Gonorrhea, Granuloma Inguinale, Hantavirus, H. Pylori, Hepatitis, Herpes Influenza, Legionella, Lyme disease, Lymphogranuloma, Malaria, Measles, Meningitis, Microsporidium, Mononucleosis, Mumps, Mycoplasma, HPV, Parvovirus, Pneumonia, Polyomaviruses, Pseudomonas, Rabies, RSV, Rhinovirus, Rotavirus , Rubella, Salmonella, Septicemia, Shigella, Staphylococci, Streptococci, Syphilis, Toxoplasmosis, Trichomonas, TB, Vibrio, West Nile, Yersinia.

Market Segmentation Analysis

- Sales and market shares of major suppliers by individual test.

- Volume and sales forecasts for over 100 infectious disease assays by individual test and market segment:

Centralized Testing

- Hospitals

- Commercial/Private Laboratories

- Blood Banks

- Public Health Laboratories

POC/Decentralized Testing

- Physician Offices/Group Practices

- Emergency Rooms

- Operating/Recovery Suites

- ICUs/CCUs

- Cancer Clinics

- Ambulatory Care Centers

- Surgery Centers

- Nursing Homes

- Birth Centers

- Test volume estimates by method (molecular, serology/immunodiagnostics, culture/microscopy).

- Review of the market dynamics, trends, structure, size, growth and major suppliers.

Current and Emerging Products

- In-depth examination of over 100 major diseases, including their etiology, current diagnostic tests, vaccines, drugs and market needs.

- Review of major analyzers used for infectious disease testing, including their operating characteristics, features and selling prices.

Technology Review

- Assessment of molecular diagnostic, monoclonal antibody,immunoassay,and other technologies and their potential applications for infectious disease testing.

- Global listings of companies developing or marketing infectious disease diagnostic products by individual test.

Competitive Assessments

- Strategic assessments of major suppliers and emerging market entrants, including their sales, product portfolios, marketing tactics, collaborative arrangements and new products in R&D.

- The companies analyzed in the report include:

- Abbott

- Affymetrix

- Beckman Coulter/Danaher

- Becton Dickinson

- Biomerieux

- Bio-Rad

- Cepheid

- Diamedix/Erba

- Diasorin

- Eiken Chemical

- Elitech Group

- Enzo Biochem

- Fujirebio

- Grifols

- Hologic/Gen-Probe

- ID Biomedical/GSK

- Kreatech/Leica

- Lonza

- Ortho-Clinical Diagnostics

- Qiagen

- Roche

- Scienion

- Sequenom

- SeraCare

- Siemens

- Takara Bio

- Thermo Fisher

- Wallac/PE

- Wako

Contains 1,060 pages and 192 tables

2018 US Infectious Disease Testing Analyzers and Reagents: Supplier Sales and Shares by Test, Sales Segment Forecasts--Hospitals, Commercial Laboratories, POC Locations--Competitive Landscape, Emerging Technologies, Instrumentation Review

Table of Contents

I. Introduction
II. Major Product Development Opportunities
A. Instrumentation
B. Reagent Kits and Test Systems/panels
C. Information Technology
D. Auxiliary Products
III. Design Criteria for Decentralized Testing Products
IV. Alternative Market Penetration Strategies
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized Testing Markets
1. Marketing Approaches
2. Product Complexity
3. Customer Preference
4. Established Suppliers
5. Emerging Suppliers
6. Major Types of Distributors
7. Market Segmentation
V. Potential Market Entry Barriers and Risks
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
Table of Contents

VI. Worldwide Overview of Major Tests, Technologies, and Instrumentation
A. Major Infectious Disease Tests
1. AIDS
2. Adenovirus
3. Aeromonas
4. Anthrax/Bacillus Anthracis
5. Arboviruses
6. Babesiosis
7. Bacillary Epithelioid Angiomatosis (BEA) and Other Bartonella (Rochalimaea)
8. Blastocystis Hominis
9. Brucella
10. Campylobacter
11. Candida
12. Chagas Disease
13. Chancroid
14. Chlamydia
15. Clostridium Difficile
16. Coronaviruses
17. Coxsackieviruses
18. Creutzfeldt-Jakob's Disease
19. Cryptosporidium Parvum
20. Cyclospora Cayetanensis
21. Cytomegalovirus
22. Ebola Virus
23. E. Coli
24. EchoVirus
25. Encephalitis
26. Enteroviruses
27. Epstein-Barr Virus
28. Giardia Lamblia
29. Gonorrhea
30. Granuloma Inguinale
31. Hantavirus
32. Helicobacter Pylori
Table of Contents

33. Hepatitis
34. Herpes Simplex Virus
35. Human Herpes Virus-6 (HHV-6)
36. Influenza Viruses
37. Legionella
38. Lyme Disease
39. Lymphogranuloma Venereum (LGV)
40. Malaria
41. Measles (Rubeola)
42. Meningitis
43. Microsporidium
44. Mononucleosis
45. Mumps
46. Mycoplasma
47. Papillomaviruses
48. Parvovirus B19
49. Pneumonia
50. Polyomaviruses
51. Pseudomonas Aeruginosa
52. Rabies
53. Respiratory Syncytial Virus (RSV)
54. RhinoViruses
55. RotaVirus (REOVIRUS)
56. Rubella(MEASLES)
57. Salmonellosis
58. Septicemia
59. Shigellosis
60. Staphylococcus Aureus
61. Streptococci
62. Syphilis
63. Toxoplasmosis
64. Trichomonas Vaginalis
65. Tuberculosis
66. Vibrio
67. West Nile Virus
68. Yersina
Table of Contents

B. Instrumentation Review: Operating Characteristics, Features and Selling Princes of Leading Automated and Semiautomated Analyzers
C. Emerging Diagnostic Technologies
1. Molecular Diagnostics
2. Monoclonal Antibodies
3. Immunoassays
4. Differential Light Scattering
5. Information Technology
6. Artificial Intelligence
7. Liposomes
8. Flow Cytometry
9. Chromatography
10. Diagnostic Imaging
11. Gel Microdroplets
12. Other
VII. U.S.A. A. Executive Summary
B. Business Environment
C. Market Structure
D. Rationale for Testing Decentralization
1. Overview
2. Regulatory Trends
3. Economic Trends
4. Demographic Trends
5. Technological Trends
6. Social Trends
7. Quality of Care
8. Defensive Medicine
9. Quality Control Issues
E. Market Size, Growth, Volume by Method, and Major Suppliers' Sales and Market Shares by Test
Table of Contents

XI. Competitive Strategies
- Abbott
- Affymetrix
- Beckman Coulter/Danaher
- Becton Dickinson
- bioMerieux
- Bio-Rad
- Cepheid
- Diamedix
- DiaSorin
- Eiken Chemical
- Elitech Group
- Enz-*Biochem
- Fujirebio
- Grifols
- Hologic/Gen-Probe
- ID Biomedical/GSK
- Kreatech/Leica
- Lonza
- Ortho-Clinical Diagnostics
- Qiagen
- Roche
- Scienion
- Sequenom
- SeraCare
- Siemens
- Takara Bio
- Therm-*Fisher
- Wallac/PE
- Wako

List of Tables

Major Companies Developing or Marketing AIDS Tests
Major Companies Developing or Marketing Adenovirus Tests
Major Companies Developing or Marketing Bartonella Tests
Major Companies Developing or Marketing Campylobacter Tests
Major Companies Developing or Marketing Candida Tests
Major Companies Developing or Marketing Chlamydia Tests
Major Companies Developing or Marketing Clostridium Tests
Major Companies Developing or Marketing Coronavirus Tests
Major Companies Developing or Marketing Cryptosporidium Tests
Major Companies Developing or Marketing CMV Tests
Major Companies Developing or Marketing Echovirus Tests
Major Companies Developing or Marketing Enterovirus Tests
Major Companies Developing or Marketing EBV Tests
Major Companies Developing or Marketing Giardia Tests
Major Companies Developing or Marketing Gonorrhea Tests
Major Companies Developing or Marketing Hantavirus Tests
Major Companies Developing or Marketing Helicobacter Pylori Tests
Major Companies Developing or Marketing Hepatitis Tests
Major Companies Developing or Marketing Herpes Tests
Major Companies Developing or Marketing Influenza Tests
Major Companies Developing or Marketing Legionella Tests
Major Companies Developing or Marketing Lyme Disease Tests
Major Companies Developing or Marketing Lymphogranuloma Tests
Major Companies Developing or Marketing Malaria Tests
Major Companies Developing or Marketing Measles Tests
Major Companies Developing or Marketing Meningitis Tests
Major Companies Developing or Marketing Microsporidium Tests
Major Companies Developing or Marketing Mononucleosis Tests
Major Companies Developing or Marketing Mumps Tests
Major Companies Developing or Marketing Mycoplasma Tests
Major Companies Developing or Marketing Papilloma Virus Tests
Major Companies Developing or Marketing Parvovirus Tests
Major Companies Developing or Marketing Pneumonia Tests
Major Companies Developing or Marketing RSV Tests
Major Companies Developing or Marketing Rotavirus Tests
Major Companies Developing or Marketing Rubella Tests
Major Companies Developing or Marketing Salmonella Tests
Major Companies Developing or Marketing Septicemia Tests
Major Companies Developing or Marketing Shigella Tests
Major Companies Developing or Marketing Staphylococci Tests
Major Companies Developing or Marketing Streptococci Tests
Major Companies Developing or Marketing Syphilis Tests
Major Companies Developing or Marketing Toxoplasmosis Tests
Major Companies Developing or Marketing Trichomonas Tests
Major Companies Developing or Marketing Tuberculosis Tests
Major Companies Developing or Marketing West Nile Tests
Major Companies Developing or Marketing Yersinia Tests
U.S.A. Summary Table All Infectious Diseases Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Laboratories Performing Infectious Disease Tests By Market Segment
U.S.A. Hospital Laboratories Performing Infectious Disease Tests by Bed Size
U.S.A. Commercial/Private Laboratories Performing Infectious Disease Tests by Annual Test Volume
U.S.A. Physician Office Laboratories Performing Infectious Disease Tests by Practice Size
U.S.A. All Market Segments Infectious Disease Test Volume Forecast
U.S.A. All Market Segments Infectious Disease Test Volume by Method
U.S.A. Hospital Laboratories Infectious Disease Test Volume Forecast
U.S.A. Blood Banks Infectious Disease Test Volume Forecast
U.S.A. Physician Office Laboratories Infectious Disease Test Volume Forecast
U.S.A. Commercial/Private Laboratories Infectious Disease Test Volume Forecast
U.S.A. Public Health Laboratories Infectious Disease Test Volume Forecast
U.S.A. All Market Segments Infectious Disease Diagnostics Market Forecast
U.S.A. Hospital Laboratories Infectious Disease Diagnostics Market Forecast
U.S.A. Blood Banks Infectious Disease Diagnostics Market Forecast
U.S.A. Physician Office Laboratories Infectious Disease Diagnostics Market Forecast
U.S.A. Commercial/Private Laboratories Infectious Disease Diagnostics Market Forecast
U.S.A. Public Health Laboratories Infectious Disease Diagnostics Market Forecast
U.S.A. HIV or HIV I/HIV II Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. HIVAg Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Western Blot/Other Confirmatory Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Adenovirus Test Volume and Diagnostics Sales Forecast By Market Segment
U.S.A. Aeromonads Test Volume and Diagnostics Sales Forecast By Market Segment
U.S.A. BEA Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Blastocystis Hominis Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Campylobacter Test Volume and Diagnostics Sales Forecast By Market Segment
U.S.A. Candida Test Volume and Diagnostics Sales Forecast By Market Segment
U.S.A. Chancroid Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Chlamydia Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Clostridium Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Coronavirus Test Volume and Diagnostics Sales Forecast By Market Segment
U.S.A. CoxsackieVirus Test Volume and Diagnostics Sales Forecast By Market Segment
U.S.A. Cryptosporidium Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Cyclospora Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. CMV Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. E. Coli Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Echovirus Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Encephalitis Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Enterovirus Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. EBV Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Giardia Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Gonorrhea Test Volume and Diagnostics Sales Forecast By Market Segment
U.S.A. Granuloma Inguinale Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Hantavirus Test Volume and Diagnostics Sales Forecast By Market Segment
U.S.A. Helicobacter Pylori Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. HAV NAT Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. HBV NAT Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. HbsAg Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Hepatitis C Test Volume and Diagnostics Sales Forecast By Market Segment
U.S.A. Anti-HBC Test Volume and Diagnostics Sales Forecast By Market Segment
U.S.A. Anti-HBS Test Volume and Diagnostics Sales Forecast By Market Segment
U.S.A. Anti-HAV Test Volume and Diagnostics Sales Forecast By Market Segment
U.S.A. Hepatitis Delta Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. HBcAg Test Volume and Diagnostics Sales Forecast By Market Segment
U.S.A. HBeAg Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. ALT/SGPT Test Volume and Diagnostics Sales Forecast By Market Segment
U.S.A. Herpes Simplex I and II Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Herpes Type VI Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. HTLV I or HTLV I/HTLV II Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Influenza Test Volume and Diagnostics Sales Forecast By Market Segment
U.S.A. Legionella Test Volume and Diagnostics Sales Forecast By Market Segment
U.S.A. Lyme Disease Test Volume and Diagnostics Sales Forecast By Market Segment
U.S.A. Lymphogranuloma Test Volume and Diagnostics Sales Forecast By Market Segment
U.S.A. Malaria Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Measles Test Volume and Diagnostics Sales Forecast By Market Segment
U.S.A. Meningitis Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Microsporidium Test Volume and Diagnostics Sales Forecast By Market Segment
U.S.A. Mononucleosis Test Volume and Diagnostics Sales Forecast By Market Segment
U.S.A. Mumps Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Mycoplasma Test Volume and Diagnostics Sales Forecast By Market Segment
U.S.A. Papilloma Virus Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Parvovirus Test Volume and Diagnostics Sales Forecast By Market Segment
U.S.A. Pneumonia Test Volume and Diagnostics Sales Forecast By Market Segment
U.S.A. Polyomaviruses Test Volume and Diagnostics Sales Forecast By Market Segment
U.S.A. Pseudomonas Test Volume and Diagnostics Sales Forecast By Market Segment
U.S.A. Rabies Test Volume and Diagnostics Sales Forecast By Market Segment
U.S.A. RSV Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Rhinovirus Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Rotavirus Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Rubella Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Salmonella Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Septicemia Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Shigella Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Staphylococci Test Volume and Diagnostics Sales Forecast By Market Segment
U.S.A. Streptococci Test Volume and Diagnostics Sales Forecast By Market Segment
U.S.A. Syphilis Test Volume and Diagnostics Sales Forecast By Market Segment
U.S.A. Toxoplasmosis Test Volume and Diagnostics Sales Forecast By Market Segment
U.S.A. Trichomonas Test Volume and Diagnostics Sales Forecast By Market Segment
U.S.A. Tuberculosis Test Volume and Diagnostics Sales Forecast By Market Segment
U.S.A. Vibri-*Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. West Nile Test Volume and Diagnostics Sales Forecast By Market Segment
U.S.A. Yersinia Test Volume and Diagnostics Sales Forecast By Market Segment
U.S.A., Ancillary Hospital Locations Estimated Number
U.S.A., Ancillary Hospital Locations Annual Utilization
U.S.A., Hospital Emergency Departments Infectious Disease Test Volume Forecast
U.S.A., Hospital Emergency Departments Infectious Disease Reagent and Instrument Sales Forecast
U.S.A., Ambulatory Care Centers Estimated Number of Facilities and Patient Visits
U.S.A., Ambulatory Care Centers Most Frequent Diagnoses
U.S.A., Ambulatory Care Centers Infectious Disease Test Volume Forecast
U.S.A., Ambulatory Care Centers Microbiology and Serology Test Volume Forecast
U.S.A., Ambulatory Care Centers Infectious Disease Reagent and Instrument Sales Forecast
U.S.A., Ambulatory Care Centers Microbiology and Serology Reagent and Instrument Sales Forecast
U.S.A., Surgery Centers Most Frequently Performed Procedures
U.S.A., Surgery Centers Microbiology and Serology Test Volume Forecast
U.S.A., Surgery Centers Microbiology and Serology Reagent and Instrument Sales Forecast
U.S.A., Birth Centers Facilities, Patient Visits, and Births
U.S.A., Birth Centers Microbiology and Serology Test Volume Forecast
U.S.A. AIDS Testing Market Diagnostics Sales by Major Supplier
U.S.A. Adenovirus Testing Market Diagnostics Sales By Major Supplier
U.S.A. Campylobacter Testing Market Diagnostics Sales By Major Supplier
U.S.A. Candida Testing Market Diagnostics Sales by Major Supplier
U.S.A. Chancroid Testing Market Diagnostics Sales by Major Supplier
U.S.A. Chlamydia Testing Market Diagnostics Sales by Major Supplier
U.S.A. CMV Testing Market Diagnostics Sales by Major Supplier
U.S.A. Cryptosporidium Testing Market Diagnostics Sales by Major Supplier
U.S.A. Echovirus Testing Market Diagnostics Sales by Major Supplier
U.S.A. Enterovirus Testing Market Diagnostics Sales By Major Supplier
U.S.A. EBV Testing Market Diagnostics Sales by Major Supplier
U.S.A. Giardia Testing Market Diagnostics Sales by Major Supplier
U.S.A. Gonorrhea Testing Market Diagnostics Sales by Major Supplier
U.S.A. Helicobacter Pylori Testing Market Diagnostics Sales by Major Supplier
U.S.A. Hepatitis Testing Market Diagnostics Sales by Major Supplier
U.S.A. Hepatitis C Testing Market Diagnostics Sales By Major Supplier
U.S.A. Herpes Testing Market Diagnostics Sales by Major Supplier
U.S.A. Influenza Testing Market Diagnostics Sales by Major Supplier
U.S.A. Legionella Testing Market Diagnostics Sales By Major Supplier
U.S.A. Lyme Disease Testing Market Diagnostics Sales By Major Supplier
U.S.A. Measles Testing Market Diagnostics Sales By Major Supplier
U.S.A. Meningitis Testing Market Diagnostics Sales by Major Supplier
U.S.A. Mononucleosis Testing Market Diagnostics Sales By Major Supplier
U.S.A. Mumps Testing Market Diagnostics Sales by Major Supplier
U.S.A. Mycoplasma Testing Market Diagnostics Sales By Major Supplier
U.S.A. Pneumonia Testing Market Diagnostics Sales by Major Supplier
U.S.A. Rabies Testing Market Diagnostics Sales by Major Supplier
U.S.A. RSV Testing Market Diagnostics Sales by Major Supplier
U.S.A. Rotavirus Testing Market Diagnostics Sales by Major Supplier
U.S.A. Rubella Testing Market Diagnostics Sales by Major Supplier
U.S.A. Salmonella Testing Market Diagnostics Sales By Major Supplier
U.S.A. Septicemia Testing Market Diagnostics Sales By Major Supplier
U.S.A. Shigella Testing Market Diagnostics Sales by Major Supplier
U.S.A. Streptococci Testing Market Diagnostics Sales By Major Supplier
U.S.A. Syphilis Testing Market Diagnostics Sales by Major Supplier
U.S.A. Toxoplasmosis Testing Market Diagnostics Sales By Major Supplier
  • Global Histone Deacetylase (HDAC) Inhibitors Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 87
    The global Histone Deacetylase (HDAC) Inhibitors market was valued at US$ 615.2 million in 2023 and is anticipated to reach US$ 1223.2 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030. North American market for Histone Deacetylase (HDAC) Inhibitors is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Histone Deacetylase (HDAC) Inhibitor......
  • Global Esomeprazole Magnesium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 74
    The global Esomeprazole Magnesium market was valued at US$ 5287 million in 2023 and is anticipated to reach US$ 9451.5 million by 2030, witnessing a CAGR of 8.3% during The forecast period 2024-2030. North American market for Esomeprazole Magnesium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Esomeprazole Magnesium is estimated to increase from $ million in 2......
  • Global Combination Therapy Drug Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Combination Therapy Drug market was valued at US$ 105 million in 2023 and is anticipated to reach US$ 166.7 million by 2030, witnessing a CAGR of 4.1% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is......
  • Global Axitinib Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 68
    The global Axitinib market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The......
  • Global Lyme Disease Vaccine Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 70
    The lyme disease vaccine can reduce lyme disease incidence, reduce symptoms and reduce mortality. Lyme disease is a tick-borne infection of spirochete, a natural disease caused by borrelia burgdorferi. The global Lyme Disease Vaccine market was valued at US$ 257 million in 2023 and is anticipated to reach US$ 763 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at......
  • Global Transdermal Absorption Patch Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Transdermal Absorption Patch market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Transdermal Absorption Patch is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Transdermal Absorption Patch is estimated to increase from $ million i......
  • Global Ketoprofen Patches Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    Ketoprofen patch, indications for The treatment of symptoms caused by The following diseases: rheumatoid arthritis and rheumatoid arthritis The global Ketoprofen Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Ketoprofen Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast per......
  • Global Methyl Salicylate Patches Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 82
    The global Methyl Salicylate Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to......
  • Global Diclofenac Patches Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Diclofenac Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs